SynthesisFrontiers in immunology2026

Safety and efficacy of anti-IL-5 monoclonal antibodies as second-line therapy for chronic rhinosinusitis with nasal polyps: a meta-analysis.

Huixiu Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.